Critical steps in hematogenous metastasis: an overview.

Metastasis is responsible for most cancer deaths. A better understanding of the process provides opportunities to develop new treatments to prevent metastasis. This article summarizes findings from experimental in vivo videomicroscopy and quantitative studies on metastatic inefficiency, which indicate that early steps in hematogenous metastasis may be quite efficient, but that regulation of cancer cell growth in secondary sites determines metastatic outcome. The authors have identified three key stages of this growth regulation: survival of a subset of single cells, proliferation of a subset of these cells to form preangiogenic micrometastases, and persistence of growth of a subset of these to form vascularized metastases. Formation of clinically relevant metastases is determined by the proportion of cells that proceeds successfully through each stage, and surviving single cells and preangiogenic micrometastases both represent possible sources of tumor dormancy.

[1]  I. Macdonald,et al.  Clinical targets for anti-metastasis therapy. , 2000, Advances in cancer research.

[2]  R. Khokha,et al.  Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. , 1995, Experimental cell research.

[3]  D. Nance,et al.  Interactions between cancer cells and the endothelium in metastasis , 2000, The Journal of pathology.

[4]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[5]  P. Gullino,et al.  Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. , 1975, Cancer research.

[6]  I. Macdonald,et al.  Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. , 2000, Cancer research.

[7]  A. Chambers.  The metastatic process: basic research and clinical implications. , 1999, Oncology research.

[8]  F. Orr,et al.  Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1alpha on metastasis and the location of B16F1 melanoma cell arrest. , 1997, Cancer research.

[9]  L. Liotta,et al.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.

[10]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.

[11]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[12]  J M Pluda,et al.  Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. , 1997, Seminars in oncology.

[13]  R. Khokha,et al.  Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. , 1995, Cancer research.

[14]  C. Culling,et al.  Cellular Pathology Technique , 1985 .

[15]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[16]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[17]  I. Macdonald,et al.  Integrin VLA-2 (alpha2beta1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liver. , 1996, Cancer research.

[18]  J. Segall,et al.  Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. , 1998, Cancer research.

[19]  I. Macdonald,et al.  Early steps in hematogenous metastasis of B16F1 melanoma cells in chick embryos studied by high-resolution intravital videomicroscopy. , 1992, Journal of the National Cancer Institute.

[20]  R. Khokha,et al.  Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[22]  J. Segall,et al.  A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. , 2000, Cancer research.

[23]  R Folberg,et al.  Vasculogenic mimicry and tumor angiogenesis. , 2000, The American journal of pathology.

[24]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[25]  R. Jain,et al.  Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity , 1999, British Journal of Cancer.

[26]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[27]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[28]  F. Orr,et al.  Effect of leukocyte activation on the formation of heterotypic tumor‐cell aggregates in vitro , 1985, International journal of cancer.

[29]  G. Naumov,et al.  Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. , 1999, Journal of cell science.

[30]  R. Khokha,et al.  Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. , 1994, Cancer research.